BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38160285)

  • 1. Generating new drug repurposing hypotheses using disease-specific hypergraphs.
    Jain A; Charpignon ML; Chen IY; Philippakis A; Alaa A
    Pac Symp Biocomput; 2024; 29():261-275. PubMed ID: 38160285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGTDR: Advancing drug repurposing with heterogeneous graph transformers.
    Gharizadeh A; Abbasi K; Ghareyazi A; Mofrad MRK; Rabiee HR
    Bioinformatics; 2024 Jul; 40(7):. PubMed ID: 38913860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing.
    Xiang S; Lawrence PJ; Peng B; Chiang C; Kim D; Shen L; Ning X
    Pac Symp Biocomput; 2024; 29():306-321. PubMed ID: 38160288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DRTerHGAT: A drug repurposing method based on the ternary heterogeneous graph attention network.
    He H; Xie J; Huang D; Zhang M; Zhao X; Ying Y; Wang J
    J Mol Graph Model; 2024 Jul; 130():108783. PubMed ID: 38677034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repurposing for COVID-19 via knowledge graph completion.
    Zhang R; Hristovski D; Schutte D; Kastrin A; Fiszman M; Kilicoglu H
    J Biomed Inform; 2021 Mar; 115():103696. PubMed ID: 33571675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision drug repurposing via convergent eQTL-based molecules and pathway targeting independent disease-associated polymorphisms.
    Vitali F; Berghout J; Fan J; Li J; Li Q; Li H; Lussier YA
    Pac Symp Biocomput; 2019; 24():308-319. PubMed ID: 30864332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computational approach to drug repurposing using graph neural networks.
    Doshi S; Chepuri SP
    Comput Biol Med; 2022 Nov; 150():105992. PubMed ID: 36228466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A machine learning and network framework to discover new indications for small molecules.
    Gilvary C; Elkhader J; Madhukar N; Henchcliffe C; Goncalves MD; Elemento O
    PLoS Comput Biol; 2020 Aug; 16(8):e1008098. PubMed ID: 32764756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases.
    Sosa DN; Derry A; Guo M; Wei E; Brinton C; Altman RB
    Pac Symp Biocomput; 2020; 25():463-474. PubMed ID: 31797619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Task-driven knowledge graph filtering improves prioritizing drugs for repurposing.
    Ratajczak F; Joblin M; Ringsquandl M; Hildebrandt M
    BMC Bioinformatics; 2022 Mar; 23(1):84. PubMed ID: 35246025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
    Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
    Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiscale topology in interactomic network: from transcriptome to antiaddiction drug repurposing.
    Du H; Wei GW; Hou T
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38499497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A network-based drug repurposing method via non-negative matrix factorization.
    Sadeghi S; Lu J; Ngom A
    Bioinformatics; 2022 Feb; 38(5):1369-1377. PubMed ID: 34875000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel computational approach for drug repurposing using systems biology.
    Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
    Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug-drug links based on graph neural network.
    Cui C; Ding X; Wang D; Chen L; Xiao F; Xu T; Zheng M; Luo X; Jiang H; Chen K
    Bioinformatics; 2021 Sep; 37(18):2930-2937. PubMed ID: 33739367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Repurposing Using Deep Embeddings of Gene Expression Profiles.
    Donner Y; Kazmierczak S; Fortney K
    Mol Pharm; 2018 Oct; 15(10):4314-4325. PubMed ID: 30001141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new computational drug repurposing method using established disease-drug pair knowledge.
    Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
    Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.